Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per thor Straten

Showing results (21-30 of 157) with videos related to

Pageof 16
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 14, 2010
Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2Annika Berntsen, Marie Klinge Brimnes, Per thor Straten, et al.
Current Opinion in Biotechnology|October 20, 2023
Nucleotide metabolism in the regulation of tumor microenvironment and immune cell functionHelena B Madsen, Marlies Jw Peeters, Per Thor Straten, et al.
International Journal of Molecular Sciences|May 31, 2020
Exercise Oncology and Immuno-Oncology; A (Future) Dynamic DuoGitte Holmen Olofsson, Agnete Witness Praest Jensen, Manja Idorn, et al.
Cancer Biology & Therapy|October 18, 2008
A survivin specific T-cell clone from a breast cancer patient display universal tumor cell lysisRikke Baek Sørensen, Inge Marie Svane, Per Thor Straten, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
The universal character of the tumor-associated antigen survivinMads Hald Andersen, Inge Marie Svane, Jürgen C Becker, et al.
Journal of Translational Medicine|September 5, 2006
HLA-A24 and survivin: possibilities in therapeutic vaccination against cancerMads Hald Andersen, Rikke B Soerensen, Jürgen C Becker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
Spontaneous immunity against Bcl-xL in cancer patientsMads Hald Andersen, Sine Reker, Pia Kvistborg, et al.
Oncoimmunology|December 18, 2012
Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytesMarco Donia, Eva Ellebaek, Mads Hald Andersen, et al.
Journal of Biomedicine & Biotechnology|July 10, 2010
Therapeutic cancer vaccines in combination with conventional therapyMads Hald Andersen, Niels Junker, Eva Ellebaek, et al.
Cancer Research|October 18, 2002
Identical T-cell receptor transcripts in multiple melanoma metastasesDavid Schrama, Eva Fuchs, Eva-Bettina Bröcker, et al.
Pageof 16

Showing results (21-30 of 157) with videos related to

Sort By:
Pageof 16
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 14, 2010
Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2Annika Berntsen, Marie Klinge Brimnes, Per thor Straten, et al.
Current Opinion in Biotechnology|October 20, 2023
Nucleotide metabolism in the regulation of tumor microenvironment and immune cell functionHelena B Madsen, Marlies Jw Peeters, Per Thor Straten, et al.
International Journal of Molecular Sciences|May 31, 2020
Exercise Oncology and Immuno-Oncology; A (Future) Dynamic DuoGitte Holmen Olofsson, Agnete Witness Praest Jensen, Manja Idorn, et al.
Cancer Biology & Therapy|October 18, 2008
A survivin specific T-cell clone from a breast cancer patient display universal tumor cell lysisRikke Baek Sørensen, Inge Marie Svane, Per Thor Straten, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
The universal character of the tumor-associated antigen survivinMads Hald Andersen, Inge Marie Svane, Jürgen C Becker, et al.
Journal of Translational Medicine|September 5, 2006
HLA-A24 and survivin: possibilities in therapeutic vaccination against cancerMads Hald Andersen, Rikke B Soerensen, Jürgen C Becker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
Spontaneous immunity against Bcl-xL in cancer patientsMads Hald Andersen, Sine Reker, Pia Kvistborg, et al.
Oncoimmunology|December 18, 2012
Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytesMarco Donia, Eva Ellebaek, Mads Hald Andersen, et al.
Journal of Biomedicine & Biotechnology|July 10, 2010
Therapeutic cancer vaccines in combination with conventional therapyMads Hald Andersen, Niels Junker, Eva Ellebaek, et al.
Cancer Research|October 18, 2002
Identical T-cell receptor transcripts in multiple melanoma metastasesDavid Schrama, Eva Fuchs, Eva-Bettina Bröcker, et al.
Pageof 16